risk factors

You have access
Clinical Verification on the Predictors for Febrile Neutropenia in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
WATARU GOTO, SHINICHIRO KASHIWAGI, KOHEI MATSUOKA, NOZOMI IIMORI, RIKA KOUHASHI, AKIMICHI YABUMOTO, KOJI TAKADA, YUKA ASANO, YUKIE TAUCHI, KANA OGISAWA, TAMAMI MORISAKI, MASATSUNE SHIBUTANI, HIROAKI TANAKA and KIYOSHI MAEDA

Anticancer Research January 2023, 43 (1) 247-254; DOI: https://doi.org/10.21873/anticanres.16156
You have access
Impact of Abdominal Aortic Calcification After Major Hepatobiliary Pancreatic Surgery: A Retrospective Cohort Study
YUKI IMAOKA, MASAHIRO OHIRA, KOKI SATO, KOUKI IMAOKA, TOMOAKI BEKKI, RYOSUKE NAKANO, SHINTARO KURODA, HIROYUKI TAHARA, KENTARO IDE, TSUYOSHI KOBAYASHI, YUKA TANAKA and HIDEKI OHDAN

Anticancer Research December 2022, 42 (12) 5983-5989; DOI: https://doi.org/10.21873/anticanres.16109
You have access
Thyroglobulin Levels as a Predictor of Papillary Cancer Recurrence After Thyroid Lobectomy
JIN-SEONG CHO and HEE KYUNG KIM

Anticancer Research November 2022, 42 (11) 5619-5627; DOI: https://doi.org/10.21873/anticanres.16070
Open Access
Evaluation of Sleep Disturbances in Patients With Bladder Cancer Scheduled for Local or Loco-regional Radiochemotherapy
DIRK RADES, SVENJA KOPELKE, STEVEN E. SCHILD, TROELS W. KJAER, SOEREN TVILSTED and TOBIAS BARTSCHT

Anticancer Research September 2022, 42 (9) 4511-4515; DOI: https://doi.org/10.21873/anticanres.15953
Open Access
Sleep Problems Prior to Radio-chemotherapy in Patients With Locally Advanced Cancer of the Esophagus or the Esophagogastric Junction
DIRK RADES, SVENJA KOPELKE, STEVEN E. SCHILD, SOEREN TVILSTED, TROELS W. KJAER and TOBIAS BARTSCHT

Anticancer Research September 2022, 42 (9) 4529-4533; DOI: https://doi.org/10.21873/anticanres.15955
You have access
Risk Factors for Xerostomia Following Radiotherapy of Head-and-Neck Cancers
BRITTA WARWAS, FLORIAN CREMERS, KARSTEN GERULL, ANKE LEICHTLE, KARL L. BRUCHHAGE, SAMER G. HAKIM, STEVEN E. SCHILD and DIRK RADES

Anticancer Research May 2022, 42 (5) 2657-2663; DOI: https://doi.org/10.21873/anticanres.15743
You have access
Estimating the Probability of Not Completing the Intended Course of Thoracic Radiotherapy for Lung Cancer
DIRK RADES, ESTHER GLATZEL, SABINE BOHNET, STEVEN E. SCHILD and ELISA M. WERNER

Anticancer Research April 2022, 42 (4) 1973-1977; DOI: https://doi.org/10.21873/anticanres.15675
You have access
A Prognostic Tool to Estimate the Risk of Pneumonitis in Patients Irradiated for Lung Cancer
ESTHER GLATZEL, ELISA M. WERNER, SABINE BOHNET and DIRK RADES

Anticancer Research April 2022, 42 (4) 2029-2032; DOI: https://doi.org/10.21873/anticanres.15683
You have access
Risk and Protective Factors for Postoperative Complications in Elderly Patients With Colorectal Cancer
TAKUYA SHIRAISHI, HIROOMI OGAWA, NAOYA OZAWA, KUNIHIKO SUGA, CHIKA KOMINE, YUTA SHIBASAKI, KATSUYA OSONE, TAKUHISA OKADA, YASUAKI ENOKIDA, MAKOTO SOHDA, KEN SHIRABE and HIROSHI SAEKI

Anticancer Research February 2022, 42 (2) 1123-1130; DOI: https://doi.org/10.21873/anticanres.15575
You have access
Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression
YONG-MIN NA, JIN-SEONG CHO and MIN-HO PARK

Anticancer Research November 2021, 41 (11) 5713-5721; DOI: https://doi.org/10.21873/anticanres.15387

Main menu

User menu

Search

risk factors

Pages